For example, pathogenic Ca2+ dysregulation is linked with RyR1 alterations in Alzheimer’s disease [15], mutant protein-induced mitochondrial dysfunction in Huntington’s disease [41], and sarcolemma fragility in dystrophinopathies [54]. This evidence concerns the gene RYR1 and early-onset autosomal dominant Alzheimer disease.